H Egami

813 total citations
27 papers, 690 citations indexed

About

H Egami is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, H Egami has authored 27 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in H Egami's work include Pancreatic and Hepatic Oncology Research (8 papers), Peptidase Inhibition and Analysis (4 papers) and Glycosylation and Glycoproteins Research (3 papers). H Egami is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Peptidase Inhibition and Analysis (4 papers) and Glycosylation and Glycoproteins Research (3 papers). H Egami collaborates with scholars based in Japan, United States and Netherlands. H Egami's co-authors include Takashi Kurizaki, Parviz M. Pour, Masahiro Ogawa, Yumi Takiyama, Michio Ogawa, Kazuya Murata, Minetaro Ogawa, Junji Yamashita, S Yamamoto and Joost Schalkwijk and has published in prestigious journals such as Gut, British Journal of Cancer and Carcinogenesis.

In The Last Decade

H Egami

26 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Egami Japan 15 309 272 149 138 94 27 690
Janyaporn Phuchareon United States 13 400 1.3× 277 1.0× 114 0.8× 105 0.8× 91 1.0× 19 666
K Mafune Japan 14 367 1.2× 147 0.5× 103 0.7× 144 1.0× 127 1.4× 28 698
Masanori Kanemura Japan 18 415 1.3× 309 1.1× 193 1.3× 123 0.9× 98 1.0× 37 920
Véronique Neaud France 14 304 1.0× 234 0.9× 146 1.0× 163 1.2× 60 0.6× 29 807
Fumie Omotehara Japan 17 454 1.5× 253 0.9× 197 1.3× 99 0.7× 65 0.7× 32 769
Tamako Konkin United States 7 319 1.0× 233 0.9× 213 1.4× 126 0.9× 123 1.3× 8 762
Edlyn Soeth Germany 11 244 0.8× 454 1.7× 212 1.4× 105 0.8× 131 1.4× 17 825
Marissa Shrader United States 9 380 1.2× 292 1.1× 158 1.1× 97 0.7× 134 1.4× 15 628
Tserenchunt Gansukh Germany 14 278 0.9× 313 1.2× 125 0.8× 138 1.0× 88 0.9× 17 729
Roger Mouawad France 21 523 1.7× 308 1.1× 177 1.2× 121 0.9× 155 1.6× 57 968

Countries citing papers authored by H Egami

Since Specialization
Citations

This map shows the geographic impact of H Egami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Egami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Egami more than expected).

Fields of papers citing papers by H Egami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Egami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Egami. The network helps show where H Egami may publish in the future.

Co-authorship network of co-authors of H Egami

This figure shows the co-authorship network connecting the top 25 collaborators of H Egami. A scholar is included among the top collaborators of H Egami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Egami. H Egami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Xiaodong, H Egami, Mayumi Abé, et al.. (2005). Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK–ERK signal transduction pathway. Journal of Clinical Pathology. 58(12). 1242–1248. 52 indexed citations
2.
Egami, H, Xiaodong Tan, Takashi Kurizaki, et al.. (2003). Analysis of the signal transduction pathway in relation to invasion and metastasis in pancreatic cancer. International Congress Series. 1255. 307–311.
3.
Zeeuwen, Patrick L.J.M., Ivonne M.J.J. van Vlijmen‐Willems, H Egami, & Joost Schalkwijk. (2002). Cystatin M / E expression in inflammatory and neoplastic skin disorders. British Journal of Dermatology. 147(1). 87–94. 35 indexed citations
4.
Yoshida, Naoya, H Egami, Junkoh Yamashita, et al.. (2002). Immunohistochemical expression of SKALP/elafin in squamous cell carcinoma of human lung. Oncology Reports. 9(3). 495–501. 23 indexed citations
5.
Beppu, Toru, Koichi Doi, Takatoshi Ishiko, et al.. (2001). [Efficacy of local ablation therapy for liver metastasis from colorectal cancer--radiofrequency ablation and microwave coagulation therapy].. PubMed. 102(5). 390–7. 11 indexed citations
6.
Hirota, Masahiko, et al.. (2000). Augmentation of UDP-GalNAc: Fucalpha1-2Gal alpha1-3 N-acetylgalactosaminyl transferase activity in nitrosamine-induced hamster pancreatic cancers.. PubMed. 19(2). 235–9. 2 indexed citations
7.
Egami, H, Kazuhiro Nakagawa, Shogo Nakano, et al.. (1999). Presence of RON receptor tyrosine kinase and its splicing variant in malignant and non-malignant human colonic mucosa.. International Journal of Oncology. 15(4). 709–14. 22 indexed citations
8.
Nakagawa, Kazuhiro, et al.. (1999). Prognostic values of MUC-1 molecule expressing cytokine receptor-like epitope and DF3 in patients with gastric carcinoma.. International Journal of Oncology. 20 indexed citations
9.
Beppu, Toru, Maho Ogawa, H Egami, et al.. (1998). [Clinical evaluation of Azasetron Hydrochloride: a new selective 5-HT3 receptor antagonist--antiemetic profile and plasma concentration in transcatheter arterial chemoembolization using CDDP for unresectable hepatocellular carcinoma].. PubMed. 25(8). 1197–202. 2 indexed citations
10.
Yamamoto, Shinichi, H Egami, Takashi Kurizaki, et al.. (1997). Immunohistochemical expression of SKALP/elafin in squamous cell carcinoma of the oesophagus. British Journal of Cancer. 76(8). 1081–1086. 20 indexed citations
11.
Egami, H, et al.. (1996). Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues. British Journal of Cancer. 73(10). 1233–1236. 104 indexed citations
12.
Murata, Kazuya, et al.. (1993). Expression of group-II phospholipase A2 in malignant and non-malignant human gastric mucosa. British Journal of Cancer. 68(1). 103–111. 51 indexed citations
13.
Yamashita, J., et al.. (1992). Abundant expression of immunoreactive endothelin 1 in mammary phyllodes tumor: possible paracrine role of endothelin 1 in the growth of stromal cells in phyllodes tumor.. PubMed. 52(14). 4046–9. 36 indexed citations
14.
Egami, H, et al.. (1992). Light microscopic immunohistochemical analysis of the distribution of group II phospholipase A2 in human digestive organs.. Journal of Histochemistry & Cytochemistry. 40(11). 1659–1664. 50 indexed citations
15.
Kurizaki, Takashi, et al.. (1992). Membrane-associated phospholipase A2 stimulates DNA synthesis in two murine fibroblasts.. PubMed. 78(1). 39–45. 12 indexed citations
16.
Tomioka, T., Åke Andrén‐Sandberg, Hideki Fujii, et al.. (1990). Comparative histopathological findings in the pancreas of cigarette smokers and non-smokers. Cancer Letters. 55(2). 121–128. 8 indexed citations
17.
18.
Takiyama, Yumi, H Egami, & Parviz M. Pour. (1990). Expression of human tumor-associated antigens in pancreatic cancer induced in Syrian hamsters.. PubMed. 136(3). 707–15. 28 indexed citations
19.
Egami, H, et al.. (1989). Establishment of hamster pancreatic ductal carcinoma cell line (PC-1) producing blood group-related antigens. Carcinogenesis. 10(5). 861–869. 58 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janyaporn Phuchareon Breakdown of academic impact, for papers by K Mafune Breakdown of academic impact, for papers by Masanori Kanemura Breakdown of academic impact, for papers by Véronique Neaud Breakdown of academic impact, for papers by Fumie Omotehara Breakdown of academic impact, for papers by Tamako Konkin Breakdown of academic impact, for papers by Edlyn Soeth Breakdown of academic impact, for papers by Marissa Shrader Breakdown of academic impact, for papers by Tserenchunt Gansukh Breakdown of academic impact, for papers by Roger Mouawad
Rankless by CCL
2026